Chest Meeting
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


COPYRIGHT © 2005 by the American College of Chest Physicians.
This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pandya, C. M.
Right arrow Articles by Arroliga, A. C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Pandya, C. M.
Right arrow Articles by Arroliga, A. C.

Pulmonary Hypertension Evaluation


Monday, October 31, 2005

10:30 AM - 12:00 PM

MEASURES OF PULMONARY HYPERTENSION (PAH) SEVERITY DO NOT IDENTIFY PATIENTS AT RISK FOR SIGNIFICANT NOCTURNAL HYPOXEMIA (NH)

Chirag M. Pandya, MD*, Omar A. Minai, MD, J. A. Golish, MD, K. McCarthy, RRT, J. Avecillas, MD and A. C. Arroliga, MD

Cleveland Clinic Foundation, Cleveland, OH

PURPOSE: NH not related to sleep-disordered breathing has been reported in patients with PAH. We describe the incidence of NH in PAH patients without parenchymal lung disease, and evaluate associated factors.

METHODS: Patients who spent >10% of the total sleep time with an SpO2 <90% were considered nocturnal desaturators (Desat). Variables analyzed included: demographics, spirometry, hemodynamics, and 6-minute walk test (6MW). Unpaired Student’s t-test and Mann-Whitney rank sum test were used to compare variables between Desat and nondesat (ND).

RESULTS: Of the 38 patients (33 F/5 M; mean age: 47, range 18-71 yrs), 26 (68%) were Desat and 12 (32%) were ND. Patients in the Desat group spent 46±27% (mean±SD) of sleep time with SpO2 <90%. Desats were older (50±12 vs 40±14; p=0.02), had higher BMI (30±5 vs 27±3; p=0.07, had lower resting SpO2 (94±3.5 vs 97±2.4; p=0.01), lower FEV1% pred. (75±12 vs 85±13; p=0.03), and higher Hb level (14.4±1.7 vs 13±1.2; p=0.02) than ND. There was no statistically significant difference in terms of hemodynamics, 6MW distance, BNP, Borg, or TSH. In the Desat group 65% (17/26) did not require supplemental oxygen during their 6MW. Patients in the Desat group undergoing sleep studies were not found to have significant OSA.

CONCLUSION: A high prevalence of NH was seen among our group of patients with PAH. The severity of NH was significant given the time spent <90% and the elevated Hb levels. NH did not correlate with accepted indices of PAH severity or with O2 need during 6MW. The inclusion of overnight oximetry in the routine work-up of patients with PAH is warranted since other indices of PAH severity or oxygen need during 6MW may not accurately identify these patients.

CLINICAL IMPLICATIONS: Overnight oximetry should be a part of the routine work-up of patients with PAH since other indices of PAH severity or oxygen need during 6MW may not accurately identify patients with nocturnal hypoxia.

DISCLOSURE: Chirag Pandya, None.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American College of Chest Physicians.